Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
805 people get ALNY articles and Market Currents by email alert.
Get email alerts on ALNY »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Tue, 4:00PM)
-
Business Wire (May 15, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 23, 2013)
-
-
-
-
-
Business Wire (Mar 5, 2013)
-
Business Wire (Feb 26, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Alnylam and Takeda Form Alliance In RNAiEben Tessari • Tue, May 27, 2008 -
-
-
-
-
-
-
-
-
-
-
7 Biotech Stocks Trading At Steep Discount To Target PriceKapitall • Thu, Nov 15, 2012 -
Casey Analyst Forecasts Explosive Biotech GrowthLife Sciences Report • Thu, Oct 11, 2012
-
-
-
-
-
China Biotech In Review: Deals, Trials And RegulationsChinaBio Today • Sun, Jul 15, 2012
-
-
-
-
-
Alnylam's CEO Discusses Q3 2012 Results - Earnings Call TranscriptMon, Nov 5, 2012 • 1 Comment
-
Alnylam Pharmaceuticals, Inc. Q2 2010 Earnings Call TranscriptThu, Aug 5, 2010 • 2 Comments
-
Alnylam Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptWed, May 5, 2010
-
Business Wire (Tue, 4:00PM)
-
Business Wire (May 15, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 23, 2013)
-
at CNBC.com (Apr 3, 2013)
-
Business Wire (Mar 5, 2013)
-
Business Wire (Feb 26, 2013)
-
at CNBC.com (Feb 22, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 16, 2013)
-
Business Wire (Jan 15, 2013)
-
Business Wire (Jan 14, 2013)
ALNY vs. ETF Alternatives
Company Description
Currently, there's no company description for ALNY.
-
- View all 0 replies
-
- View all 0 replies
-
Ryan Mallory
Morning Coffee, Day Trading Watchlist: $AAPL $CRUS $ALNY | SharePlanner http://bit.ly/U0LMwD - View all 0 replies
-
- View all 0 replies
-
The Scientist
SRPT has superior RNA technology. ALNY has superior RNA delivery tech (via MIT collaboration). Acquire both and potential is limitless - View all 0 replies
-
- View all 7 replies
-
-
phemale60: has some useful information but I guess they are also trying to push their Biotech Supertrader program. Love their "quote of the day"!
-
Michael Bryant
Alnylam Pharmaceuticals (ALNY) has a nice chart. Looks a little like another rounded bottom. http://bit.ly/wZi3Vx - View all 0 replies
-
- View all 0 replies
-
David White
ALNY up approx. 50% since my article in early Dec. 2011. Love it when a call works well. - View all 0 replies
-
Jim Van Meerten
ALNY - 96% Barchart technical buy signal - 15 new highs and up 27.02% in the last month - Relative Strength Index 68.01% - View all 0 replies
LATEST REPLIES
-
- View all 7 replies
-
-
phemale60: has some useful information but I guess they are also trying to push their Biotech Supertrader program. Love their "quote of the day"!